These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3726077)

  • 21. FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices.
    Goode J; Sapirstein W; Zuckerman B
    Catheter Cardiovasc Interv; 2007 May; 69(6):920-1. PubMed ID: 17455345
    [No Abstract]   [Full Text] [Related]  

  • 22. Can we eliminate placebo in ALS clinical Trials?
    Simmons Z
    Muscle Nerve; 2009 Jun; 39(6):861-5. PubMed ID: 19382170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS treatment drugs: clinical trials and compassionate use.
    Levine RJ
    AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
    Feigal D
    AIDS Treat News; 1997 Jun; (No 273):1-5. PubMed ID: 11364399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trials on trial.
    Nature; 2008 May; 453(7194):427-8. PubMed ID: 18497763
    [No Abstract]   [Full Text] [Related]  

  • 27. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D
    Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
    James JS
    AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocol design.
    Wilensky AJ
    Epilepsy Res Suppl; 1993; 10():107-13. PubMed ID: 8251086
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug interaction studies: study design, data analysis, and implications for dosing and labeling.
    Huang SM; Temple R; Throckmorton DC; Lesko LJ
    Clin Pharmacol Ther; 2007 Feb; 81(2):298-304. PubMed ID: 17259955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.
    Cohen J;
    AIDS Read; 2001 Jan; 11(1):41-2. PubMed ID: 11215087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placebo in clinical drug trials--a multidisciplinary review.
    Haegerstam G; Huitfeldt B; Nilsson BS; Sjövall J; Syvälahti E; Wahlén A
    Methods Find Exp Clin Pharmacol; 1982; 4(4):261-78. PubMed ID: 6750286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDA insists on more women in drug trials.
    Josefson D
    BMJ; 1997 Oct; 315(7112):833. PubMed ID: 9353497
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacometrics at FDA: evolution and impact on decisions.
    Powell JR; Gobburu JV
    Clin Pharmacol Ther; 2007 Jul; 82(1):97-102. PubMed ID: 17538553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA: manufacturers can use available research to verify safety of reuse.
    Neumann ME
    Nephrol News Issues; 1994 Sep; 8(9):9, 11. PubMed ID: 7935894
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA to weigh test of blood substitute out of public view.
    Burton T
    Wall St J (East Ed); 2006 Jul; ():D3. PubMed ID: 16906688
    [No Abstract]   [Full Text] [Related]  

  • 37. [The ethical dilemma of placebos].
    Agostoni A
    Recenti Prog Med; 2000 Nov; 91(11):549-51. PubMed ID: 11125945
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA wants to invite women into drug trials earlier.
    Watson T
    Nature; 1992 Nov; 360(6402):289. PubMed ID: 1448138
    [No Abstract]   [Full Text] [Related]  

  • 39. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 40. When do the federal regulations allow placebo-controlled trials in children?
    Miller FG; Wendler D; Wilfond B
    J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.